Atlas Trials

In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline

Clinical trial NCT04468568 · COMPLETED

Trial details

NCT number
NCT04468568
Sponsor
University of Sao Paulo General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
MyelomeningoceleTerbutaline Adverse ReactionPregnancy; Malformation Central Nervous System
Start date
2017-10-01
Primary completion
2020-01-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.